Lv5
1030 积分 2023-08-15 加入
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
28天前
已关闭
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
1个月前
已完结
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion
8个月前
已完结
Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer
8个月前
已完结
HER-2 positive gastric cancer: Current targeted treatments
8个月前
已完结
皖公网安备34019202002308
